Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksConvaTec Regulatory News (CTEC)

Share Price Information for ConvaTec (CTEC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 257.80
Bid: 257.20
Ask: 257.60
Change: -17.80 (-6.46%)
Spread: 0.40 (0.156%)
Open: 267.80
High: 268.40
Low: 255.80
Prev. Close: 275.60
CTEC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AGM Corrected Poll Result

11 May 2018 15:27

RNS Number : 8674N
ConvaTec Group PLC
11 May 2018
 

 

Result of Meeting

 

 

CONVATEC GROUP PLC - AGM

11 MAY 2018 - CORRECTED POLL RESULT

 

ConvaTec Group Plc ("ConvaTec"), a leading global medical products and technologies company, held its annual general meeting today. The results of the poll held in relation to the resolutions proposed at the meeting are set out below. The number of votes withheld has been corrected and a column of number of votes cast included.

 

 

For (see note 2)

Against (see note 2)

Number of votes withheld (see note 3)

Number of votes cast

Total Capital Instructed

Resolution

No of shares

%

No of Shares

%

 

1

Receive Annual Report and Accounts

1,490,995,091

100.00

2,052

0.00

429,366

 

1,490,997,143

76.39%

2

Approve the Directors' Remuneration Report

1,457,090,861

98.33

24,766,857

1.67

 

9,568,789

 

1,481,857,718

75.92%

3

Declare Final Dividend

1,490,997,143

100.00

0

0.00

429,366

 

1,490,997,143

76.39%

4

Re-elect Sir Christopher Gent as a Director

1,483,108,674

99.47

7,885,399

0.53

432,436

 

1,490,994,073

76.39%

5

Re-elect Paul Moraviec as a Director

1,488,939,928

99.86

2,054,145

0.14

432,436

 

1,490,994,073

76.39%

6

Elect Frank Schulkes as a Director

1,481,688,827

99.38

9,305,246

0.62

 

432,436

 

1,490,994,073

76.39%

7

Re-elect Steve Holliday as a Director

1,482,717,535

99.44

8,277,540

0.56

431,434

 

1,490,995,075

76.39%

8

Re-elect Jesper Ovesen as a Director

1,476,891,196

99.05

14,102,877

0.95

432,436

 

1,490,994,073

76.39%

9

Re-elect Rick Anderson as a Director

1,488,985,560

99.87

2,009,487

0.13

 

431,462

 

1,490,995,047

76.39%

10

Re-elect Kasim Kutay as a Director

1,488,564,111

99.84

2,429,436

0.16

 

432,962

 

1,490,993,547

76.39%

11

Elect Ros Rivaz as a Director

1,486,522,754

99.70

4,471,319

0.30

 

432,436

 

1,490,994,073

76.39%

12

Elect Regina Benjamin as a Director

1,488,488,383

99.83

2,506,166

0.17

 

431,960

 

1,490,994,549

76.39%

13

Elect Margaret Ewing as a Director

1,488,980,460

99.86

2,014,587

0.14

 

431,462

 

1,490,995,047

76.39%

14

Re-appoint Deloitte LLP as auditors

1,490,989,671

100.00

6,418

0.00

 

430,420

 

1,490,996,089

76.39%

15

Authorise the Directors to agree the auditors' remuneration

1,490,994,110

100.00

3,033

0.00

 

 

429,366

 

 

1,490,997,143

76.39%

16

Authorise allotment of shares

1,479,661,716

99.25

11,131,674

0.75

 

633,119

 

1,490,793,390

76.38%

17

Disapply pre-emption rights*

1,490,781,972

99.99

213,817

0.01

 

430,720

 

1,490,995,789

76.39%

18

Disapply pre-emption rights in connection with an acquisition or specified capital investment*

1,428,938,102

95.84

62,052,586

4.16

 

 

 

435,820

 

 

 

1,490,990,688

76.39%

19

Authorise purchase of own shares*

1,485,284,913

99.75

3,698,352

0.25

 

2,443,243

 

1,488,983,265

76.29%

20

Authorise political donations and political expenditure

1,485,209,550

99.91

1,303,630

0.09

 

 

4,913,329

 

 

1,486,513,180

76.16%

21

Call general meetings on 14 days' notice*

1,442,987,025

97.07

43,526,671

2.93

4,912,813

 

1,486,513,696

76.16%

 

*Special Resolution

 

 

NOTES:

 

1. All resolutions were passed.

2. Votes "For" and "Against" are expressed as a percentage of votes received.

3. A "Vote withheld" is not a vote in law and is not counted in the calculation of the votes "For" or "Against" a resolution.

4. Total number of shares in issue at 6.30pm on 8 May 2018 was 1,951,850,599 shares. Up to 76.39% of voting capital was instructed.

 

 

 

 

 

About ConvaTec

ConvaTec is a global medical products and technologies company focused on therapies for the management of chronic conditions. The Company is listed on the London Stock Exchange (stock symbol: CTEC) and has leading market positions in advanced wound care, ostomy care, continence and critical care, and infusion devices. ConvaTec's products provide a range of clinical and economic benefits, including infection prevention, protection of at-risk skin, improved patient outcomes and reduced total cost of care. www.convatecgroup.com

 

 

This information is provided by RNS

The company news service from the London Stock Exchange

 

Enquiries

 

Analysts and Investors

 

John Crosse, VP Investor Relations +44 (0)7500 141 435

Kirsty Law, Director Investor Relations +44 (0)7470 909 582

investorrelations@convatec.com

 

Media

 

Bobby Leach, VP Group Corporate Affairs +44 (0)7770 842 226

Finsbury +44 (0)207 251 3801 

ConvaTec Group Plc's LEI code is 213800LS272L4FIDOH92

# # #

END

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
AGMSFDFLFFASEEI
Date   Source Headline
16th Aug 202212:00 pmEQSConvatec Group PLC: Director/PDMR Shareholding
16th Aug 202212:00 pmEQSConvatec Group PLC: Director/PDMR Shareholding
4th Aug 20227:00 amRNSInterim Results
7th Jul 202211:53 amRNSDirector Declaration
28th Jun 20225:26 pmRNSBlock listing Interim Review
31st May 20222:00 pmRNSTotal Voting Rights
19th May 202210:00 amRNSDirector/PDMR Shareholding
12th May 20224:25 pmRNSResult of AGM
12th May 20227:00 amRNSAGM Trading Update
4th May 20223:31 pmRNSScrip Dividend - Total Issued Shares
3rd May 20227:00 amRNSNotice of Forthcoming Scheduled IR Events
7th Apr 20223:45 pmRNSScrip Dividend – Calculation Price
1st Apr 20224:00 pmRNSHolding(s) in Company
31st Mar 20223:45 pmRNSTotal Voting Rights
30th Mar 202212:00 pmRNSAnnual Report and Accounts 2021 and Notice of AGM
25th Mar 20222:00 pmRNSDirector/PDMR Shareholding
23rd Mar 202211:30 amRNSDirector/PDMR Shareholding
17th Mar 20222:40 pmRNSDirector/PDMR Shareholding
17th Mar 20222:20 pmRNSBoard Change
14th Mar 20227:00 amRNSAcquisition Completion of Triad Life Sciences Inc
8th Mar 20227:00 amRNSAnnual Results
28th Feb 202211:00 amRNSNon-Executive Director Changes
10th Feb 20223:15 pmRNSHolding(s) in Company
28th Jan 20227:00 amRNSAcquisition: entry into attractive wound biologics
27th Jan 202211:00 amRNSBoard Committee Changes
20th Dec 20218:45 amRNSBlock Listing Application
16th Dec 20212:00 pmRNSNon-Executive Director appointment
9th Dec 20217:00 amRNSChief Financial Officer succession
1st Nov 20213:35 pmRNSTotal Voting Rights
29th Oct 20217:00 amRNSQ3 Trading Update
18th Oct 20214:30 pmRNSDirector/PDMR Shareholding
1st Oct 20217:00 amRNSPricing of $500M 3.875% Senior Notes due 2029
30th Sep 20211:13 pmRNSConvaTec Announces Offer of $500M Senior Notes
28th Sep 20213:15 pmRNSScrip Dividend - Total Issued Shares
9th Sep 20213:00 pmRNSScrip Dividend - Calculation Price
30th Jul 20213:45 pmRNSDirector/PDMR Shareholding
30th Jul 20217:00 amRNSInterim Results
28th Jun 202112:40 pmRNSDirector Declaration
1st Jun 202111:45 amRNSTotal Voting Rights
17th May 20213:15 pmRNSDirector/PDMR Shareholding
7th May 20212:50 pmRNSResult of AGM
29th Apr 20217:00 amRNSQ1 Trading Update
28th Apr 202112:45 pmRNSScrip Dividend - Total Issued Shares
12th Apr 20213:15 pmRNSScrip Dividend - Calculation Price
22nd Mar 20213:40 pmRNSAnnual Report and Accounts 2020 and Notice of AGM
11th Mar 20213:50 pmRNSDirector/PDMR Shareholding
5th Mar 20217:00 amRNSAnnual Results
22nd Feb 202111:30 amRNSDirector Declaration
21st Dec 202011:00 amRNSDirector Declaration
30th Nov 20203:45 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.